产地国家：日本　 处 方 药：是 所属类别：10毫升/瓶 10瓶/盒 包装规格：10毫升/瓶 10瓶/盒 计价单位：盒 生产厂家中文参考译名：参天制药 生产厂家英文名：Santen Pharmaceutical 原产地英文商品名：Mydrin-P ophthalmic solution(ミドリンP点眼液)10ml/Vial 10Vial/box 原产地英文药品名：Tropicamide/Phenylephrine Hydrochloride 中文参考商品译名：Mydrin-P(ミドリンP点眼液)10毫升/瓶 10瓶/盒 中文参考药品译名：托吡卡胺/盐酸去氧肾上腺素

简介

部份中文复方托吡卡胺处方资料(仅供参考) 药品英文名：Tropicamide/Phenylephrine 药品别名：复方托吡卡胺、Compound Tropicamide 药物剂型：复方托吡卡胺滴眼液：含0.5%吡卡胺和0.5%苯肾上腺素。 药理作用：本品由托吡卡胺及苯肾上腺素组成。托吡卡胺具有阿托品样的副交感神经抑制作用，药物吸收后可引起散瞳及调节麻痹，苯肾上腺素具有交感神经兴奋作用，吸收后表现为散瞳及局部血管收缩。 药动学：临床常用0.5%托吡卡胺与0.5%苯肾上腺素复合滴眼液，两药合用有协同散瞳作用，具有减少用药量及减轻不良反应的功效。本品滴眼后5～10min开始散瞳，15～20min达峰值，维持1.5h，以后瞳孔开始恢复，5～10h瞳孔恢复至滴药前水平。 适应证：眼部散瞳检查和散瞳验光。 禁忌证：对本品过敏者和闭角型青光眼患者禁用。 注意事项 1.有眼压升高因素的前房角狭窄和前房浅者慎用。 2.高血压、动脉硬化、冠状动脉供血不足、糖尿病、甲状腺功能亢进者慎用。 3.出现过敏症状或眼压升高等情况应停用。 4.本品的特点是作用强、起效快、持续时间短。瞳孔散大后约有5～10h的畏光及近距离阅读困难的现象。 5.滴药后压迫内眦部片刻，防止通过鼻泪管吸收过多，引起副作用。 6.溶液变色或有沉淀时勿再使用。 不良反应 1.眼部：偶见局部刺激症状。可使闭角型青光眼患者的眼压暂时轻度升高，由于苯肾上腺素本身具有降眼压的作用，将不会导致视神经的损害。 2.全身：不良反应少见。 用法用量 滴入结膜囊 1.散瞳检查：每次1滴，隔5分钟滴第2次，即可满足散瞳检查之需要。 2.屈光检查：用本品每5分钟滴眼1次，连续滴4次，20min后可作屈光检查。考虑到残余调节力的存在，故不适用于少年儿童的散瞳验光。 包装规格:塑料滴管：5毫升×10本，10毫升 生产商：参天制药有限公司

英文版说明书

Mydrin-P ophthalmic solution(Tropicamide/Phenylephrine Hydrochloride) Mydrin-P ophthalmic solution(ミドリンP 点眼液) Brand name : Mydrin-P ophthalmic solution Active ingredient: Tropicamide Phenylephrine hydrochloride Dosage form: colorless to faint yellow, limpid, ophthalmic solution, 5 or 10mL, (bottle) pale violet, (cap) white Print on wrapping: Effects of this medicine This medicine acts on the muscle of parasympathetic innervation and eases the tension of the eye, or acts on the muscle of sympathetic innervation and contracts it in order to dilate the pupil, or in order to loosen the muscle of focus adjustment. It is usually used to treat inflammation of the eye such as iritis, or to improve focus adjustment of the eye. It is also used to examine eyeground or refraction of the eye. Before using this medicine, be sure to tell your doctor and pharmacist •If you have previously experienced any allergic reactions (itch, rash, etc.) to any medicines. If you have: glaucoma, predisposition of increased intraocular pressure such as narrow angle or shallow anterior chamber, hypertension, arteriosclerosis, heart disease, diabetes, or hyperthyroidism. If you wear contact lenses. •If you are pregnant or breastfeeding. •If you are taking any other medicinal products. (Some medicines may interact to enhance or diminish medicinal effects. Beware of over-the-counter medicines and dietary supplements as well as other prescription medicines.) Dosing schedule (How to take this medicine) •Your dosing schedule prescribed by your doctor is <> •For mydriasis: In general, apply 1 to 2 drops at a time, or apply 1 drop at a time, 2 times at intervals of 3 to 5 minutes. For accommodation paralysis: In general, apply 1 drop at a time, 2 to 3 times at intervals of 3 to 5 minutes. In any case, the dosage may be adjusted according to your symptoms. Strictly follow the instructions. •If you are a child patient, you should especially follow your doctor's instructions. •Before applying, wash your hands thoroughly with soap and running water. Pull down your lower eyelid so that the dropper tip does not touch eye or eyelashes and apply the medicine. After applying, keep your eyes closed for 1 to 5 minutes pressing the inner corner of the eye lightly. Wipe off any excess liquid with a clean gauze or tissue. If you need to apply other eye drops at the same time, wait more than 5 minutes. •If you miss a dose, apply the missed dose as soon as possible. If it is almost time for the next dose, skip the missed dose and continue your regular dosing schedule. You should not apply two doses at one time. •If you accidentally apply more than your prescribed dose, consult with your doctor or pharmacist. •Do not stop applying this medicine unless your doctor instructs you to do so. Precautions while taking this medicine •This medicine may cause sensitive to bright light or blurred vision. Do not operate dangerous machinery such as driving a car until these symptoms recover. If your eyes become more sensitive to bright light, wear sunglasses as necessary. •Effects of this medicine may carry over after applying for the examination. If you continue having the pupil is larger than usual (right and left pupils are different-sized), blurred vision, sensitive to bright light than usual, headache/eye pain (without typical reason such as cold) on the next day, contact the person in charge of the examination or see your doctor immediately. Possible adverse reactions to this medicine The commonly reported adverse reactions include blepharitis (erosion of eyelids, redden/swollen eyelids), eyelid dermatitis, itch, rash, hives, conjunctivitis (bloodshot/swollen eyes, eye mucus), corneal epithelial disorder (eye pain, focus disorder, foreign body sensation in eyes), increased intraocular pressure (eye pain, focus disorder, headache), dry mouth, nausea/vomiting, flush face (red face), tachycardia, increased blood pressure, and headache. If any of these symptoms occur, consult with your doctor or pharmacist. The symptoms described below are rarely seen as initial symptoms of the adverse reactions indicated in brackets. If any of these symptoms occur, stop taking this medicine and see your doctor immediately. •erythema, respiratory distress, swollen eyelids [shock, anaphylactoid symptoms] The above symptoms do not describe all the adverse reactions to this medicine. Consult with your doctor or pharmacist if you notice any symptoms of concern other than those listed above. Storage conditions and other information •Keep out of reach of children. Store away from direct sunlight and heat. •Discard the remainder. Do not store them. Santen Pharmaceutical Co.,Ltd.External Revised: 8/2015 The information on this sheet is based on approvals granted by the Japanese regulatory authority. Approval details may vary by country. Medicines have adverse reactions (risks) as well as efficacies (benefits). It is important to minimize adverse reactions and maximize efficacy. To obtain a better therapeutic response, patients should understand their medication and cooperate with the treatment.